Results 11 to 20 of about 34,408 (308)

The Cost-Effectiveness of Emergency Hormonal Contraception with Ulipristal Acetate versus Levonorgestrel for Minors in France. [PDF]

open access: yesPLoS ONE, 2015
OBJECTIVE:To evaluate the cost-effectiveness of ulipristal acetate and levonorgestrel in minors in France, and analyze whether it is worthwhile to provide ulipristal acetate to minors free of charge.
Ramona Schmid
doaj   +5 more sources

Pulmonary absorption of liposomal levonorgestrel [PDF]

open access: greenAAPS PharmSciTech, 2004
The purpose of these studies was to achieve desired bioavailability after pulmonary administration of Levonorgestrel (LN) and to provide prolonged effective concentration of the drug in plasma and to reduce reported side effects of orally administered drug.
Aliasgar Shahiwala, Ambikanandan Misra
openalex   +5 more sources

Levonorgestrel intrauterine device as a non-invasive approach of abnormal uterine bleeding caused by cesarean scar defect [PDF]

open access: yesRomanian Medical Journal, 2021
Cesarean scar defect, niche or isthmocele represents a poor healing in the anterior uterine wall after performing a cesarean section. The cesarean scar defect can be asymptomatic, or the patient could present abnormal uterine bleeding, chronic pelvic ...
Roxana-Elena Bohiltea   +7 more
doaj   +1 more source

A Randomized Clinical Trial of Levonorgestrel Intrauterine System with or without Metformin for Treatment of Endometrial Hyperplasia without Atypia in Indian Women

open access: yesAsian Pacific Journal of Cancer Prevention, 2021
Background: Endometrial cancer is the second most frequent genital malignancy in women, which is showing a constant rise all over world. Endometrial hyperplasia is the precursor of endometrial cancer.
R. Ravi   +6 more
semanticscholar   +1 more source

Levonorgestrel intrauterine system embedded within tubal ectopic pregnancy: a case report

open access: yesJournal of Medical Case Reports, 2021
Background The presence of the levonorgestrel-releasing intrauterine system embedded within an ectopic pregnancy is a rare occurrence. Tubal migration of an intrauterine device is not well understood and has not been extensively studied in literature ...
Dorothy Makena   +2 more
doaj   +1 more source

Silk Fibroin Microneedle Patches for the Sustained Release of Levonorgestrel

open access: yesACS Applied Bio Materials, 2020
The sustained release of levonorgestrel, a contraceptive, from silk-based microneedle patches was demonstrated for transdermal delivery. Modifications in the formulation of the silk protein and drug loading enabled the tuning of drug loading and release ...
B. Yavuz   +5 more
semanticscholar   +1 more source

Levonorgestrel‐releasing intrauterine system and breast cancer risk: A systematic review and meta‐analysis

open access: yesActa Obstetricia et Gynecologica Scandinavica, 2020
Epidemiological studies have shown that some hormonal contraceptive methods are associated with increased breast cancer risk, especially if used over long periods.
L. Conz   +6 more
semanticscholar   +1 more source

Effects of Levonorgestrel and progesterone on Oviductal physiology in mammals

open access: yesReproductive Biology and Endocrinology, 2018
Background Our previous study indicated that emergency contraception, including levonorgestrel and progesterone, could lead to ectopic pregnancy following contraception failure. However, our understanding of the effects of levonorgestrel and progesterone
Cheng Li   +14 more
doaj   +1 more source

Biodegradable hollow fibres for the controlled release of drugs [PDF]

open access: yes, 1988
Biodegradable hollow fibres of poly-l-lactic acid (PLLA) filled with a suspension of the contraceptive hormone levonorgestrel in castor oil were implanted subcutaneously in rats to study the rate of drug release, rate of biodegradation and tissue ...
Eenink, M.J.D.   +7 more
core   +3 more sources

Exploring Trehalose on the Release of Levonorgestrel from Implantable PLGA Microneedles

open access: yesPolymers, 2020
Hydrophobic drugs wrapped in poly (lactic-co-glycolic acid) (PLGA)-based microneedles (MNs) require a long time to release completely. To obtain the desired duration, it is still necessary to modulate the release of hydrophobic drugs from MNs, while the ...
Xiaoyu Zhao   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy